Published in Lupus on May 01, 2008
Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets. Immunol Res (2009) 1.24
Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus. Arthritis Rheum (2010) 1.13
[Recommendation for use of belimumab for systemic lupus erythematosus]. Z Rheumatol (2013) 0.83
PPARγ Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us? PPAR Res (2013) 0.80
Two negative randomized controlled trials in lupus: now what? F1000 Med Rep (2009) 0.75
Targeted silencing of DNA-specific B cells combined with partial plasma cell depletion displays additive effects on delaying disease onset in lupus-prone mice. Clin Exp Immunol (2013) 0.75
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE). Pharmaceuticals (Basel) (2010) 0.75
[Novel B-cell directed strategies for the treatment of rheumatic diseases]. Z Rheumatol (2009) 0.75